NLS Pharmaceutics’ $20 Million IPO And Listing on Nasdaq

Paolo Bossi Europe, Europe Legal Chronicle

Lenz & Staehelin acted as Swiss counsel to the underwriters. NLS Pharmaceutics Ltd priced its USD 20 million IPO of 4,819,277 units with each unit consisting…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here